Patent Grant
11859081
The invention relates to additives for polyesters used to make thermoformed, injection molded, or extruded products. More specifically, the invention relates to a thermoset polyester additive substantially derived from renewable resources.
There has been explosive growth world-wide in recent years in the field of bioplastics. This growth has been driven by environmental concerns, waste disposal challenges, and consumer demand for sustainable products. Bioplastics is a broad term that is used for biobased, biodegradable, or both biobased and biodegradable plastics. An example of bioplastics is thermoplastic biopolyesters. Thermoplastic biopolyesters exhibit a wide range of properties from brittle to elastomeric, depending on chain structure.
In spite of the potential of thermoplastic biopolyesters, only a few are used on a commercial scale. Challenges such as high production costs, slow crystallization rates, and low melt strength are associated with slow acceptance of biopolyesters in high value added engineering applications since these challenges restrict processability of biopolyesters under standard polymer processing operations. Other challenges of biopolyesters include their hygroscopic nature, susceptibility to degradation, and poor engineering properties. Improving the properties of biopolyesters to performance-match petroleum-based polymers is desired. One such goal is achieving fully biobased, biodegradable, and cost-effective formulations that have engineering properties suitable for value-added applications. Accordingly, manufacturing polymer-based products from renewable resources is desired.
Poly(lactid acid) (PLA, also known as polylactide) is a renewable-resource based aliphatic polyester, which can be biodegradable and compostable under favourable conditions. PLA is a versatile thermoplastic polyester, with properties that are comparable to petroleum-based commodity polymers. Therefore, it is viewed as a viable sustainable alternative to petroleum-sourced plastics. As part of the drive for increased renewable content in products, thermoplastic products made out of PLA have attracted considerable attention in sectors such as consumer goods, packaging, foams, and recently more high-end applications such as automotive.
Since it is a linear polyester, PLA crystallizes slowly which results in poor mechanical properties and extended processing times. These properties mean timeframes for PLA processing differ from timeframes for petroleum-based polymer processing, which make it difficult to adapt PLA to conventional polymer manufacturing processes. The time that these materials take to crystallize from the melt can be a few hours, which is too long compared to most conventional thermoplastic polyesters. This makes them difficult to melt process in a cost-effective way using conventional techniques like injection molding, thermoforming, extrusion, etc. To counteract the slow crystallization, post-processing annealing is required. Given the shortcomings of PLA, there is a need for modification to improve its processability.
In one aspect, a composite material is provided that includes thermoplastic polyester, and a particulate additive comprising a thermoset biopolyester, wherein the particulate additive reinforces and nucleates the thermoplastic polyester. In one embodiment, the thermoplastic polyester is biodegradable or bioderived or both. In one embodiment, the thermoplastic polyester is a non-bioderived polyester. In one embodiment, the thermoplastic polyester is polyethylene terephthalate (PET), polybutylene terephthalate (PBT), polycaprolactone (PCL), polyethylene succinate (PES), polybutylene succinate (PBS), poly(butylene adipate-co-terephthalate) (PBAT), or a combination thereof. In one embodiment, the thermoplastic polyester is poly(lactide) (PLA), poly-3-(hydroxyalkanoate) (PHA), polyhydroxybutyrate (PHB), poly(3-hydroxybutyrate-co-3-hydroxyvalerate (PHBV), or a combination thereof. In one embodiment, the thermoplastic polyester is poly(lactide) (PLA). In one embodiment, the thermoset biopolyester comprises biopolyester, free radical initiator, and a crosslinking agent. In one embodiment, the amount of crosslinking agent is about 0.5 wt % to about 2.5 wt % of the thermoset biopolyester. In one embodiment, the crosslinking agent is an allylic or acrylate crosslinking agent. In one embodiment, the crosslinking agent comprises TAM or TAIP. In one embodiment, an amount of free radical initiator is about 0.3 to about 2.5 wt % of the thermoset biopolyester. In one embodiment, the free radical initiator is DCP, Luperox® L101, or Luperox® L130. In one embodiment, the composite material is about 80 to about 99.9 wt % biobased. In one embodiment, a ratio of thermoplastic polyester to thermoset biopolyester by weight is 99:1, 90:10, 80:20, 70:30, 60:40, or 50:50.
In one aspect, the invention provides a biobased additive that includes a particulate of thermoset biopolyester, wherein the biobased additive is suitable for reinforcing and nucleating thermoplastic polyester. In one embodiment, the thermoset biopolyester comprises poly(lactide) (PLA), poly-3-(hydroxyalkanoate) (PHA), polyhydroxybutyrate (PHB), poly(3-hydroxybutyrate-co-3-hydroxyvalerate (PHBV), polycaprolactone (PCL), poly(butylene adipate-co-terephthalate) (PBAT), polyethylene succinate (PES), polybutylene succinate (PBS), or a combination thereof. In one embodiment, the thermoset biopolyester comprises PLA, dicumyl peroxide (DCP), and triallyl trimesate (TAM), or triallyl isocyanurate (TAIC), or a combination thereof. In one embodiment, the biobased additive includes about 95 to about 99% by weight bioderived content. In one embodiment, the thermoset biopolyester has a particle size of about 10 to about 150 micrometers. In one embodiment, the thermoset biopolyester comprises biopolyester, a free-radical initiator, and an allylic or acrylate crosslinking agent. In one embodiment, the thermoset biopolyester comprises about 20% or higher of gel content. A
In one aspect, the invention provides a method of making the composite material of the above aspect, that includes preparing thermoset biopolyester by heating biopolyester to a temperature sufficient to (i) melt the biopolyester, and (ii) decompose a selected free radical initiator, adding about 0.5 to about 2.5 wt % of the free radical initiator and about 0.5 to about 2.5 wt % of a crosslinking agent to the biopolyester, and mixing until thermoset biopolyester particles form, optionally reducing particle size by continued mixing and/or grinding the particles, adding thermoplastic polyester, and forming reinforced thermoplastic polyester. In one embodiment, the thermoplastic polyester is a biopolyester. In one embodiment, the biopolyester of the thermoplastic polyester and the biopolyester of the thermoset biopolyester are the same. In one embodiment, the biopolyester is PLA. In one embodiment, the reinforced thermoplastic polyester has a ratio of thermoplastic polyester to thermoset biopolyester of 99:1, 95:5, 90:10, 80:20, 70:30, 60:40, or 50:50 by weight. In one embodiment, the mixing is performed in an internal batch mixer. In one embodiment, the grinding is performed in a ball milling machine, or a wet mill microgrinder. In one embodiment, the method further includes isothermal conditioning between about 80 to about 120° C.
In one aspect, the invention provides a method of making the biobased additive of the above aspect, including heating biopolyester to a temperature sufficient to (i) melt the biopolyester, and (ii) decompose a selected free radical initiator, adding about 0.5 to about 2.5 wt % of the selected free radical initiator and about 0.5 to about 2.5 wt % of a crosslinking agent to the biopolyester, mixing until particles of thermoset biopolyester form, and optionally reducing particle diameter by continued mixing and/or grinding the particles. In one embodiment, the biobased additive has a particle size of about 10 to about 150 micrometers.
In one aspect, the invention provides a method of reinforcing and melt strengthening thermoplastic polyester, including adding the biobased additive of the above aspect to uncrosslinked thermoplastic polyester. In one embodiment, the adding is performed in a melt state of the thermoplastic polyester. In one embodiment, the thermoplastic polyester is polyethylene terephthalate (PET), polybutylene terephthalate (PBT), polycaprolactone (PCL), polyethylene succinate (PES), polybutylene succinate (PBS), poly(butylene adipate-co-terephthalate) (PBAT), polylactide (PLA), poly-3-(hydroxyalkanoates) (PHAs), polyhydroxybutyrate (PHB), poly(3-hydroxybutyrate-co-3-hydroxyvalerate (PHBV), or a combination thereof. In one embodiment, the adding comprises dry mixing or melt compounding. In one embodiment, the method further includes thermoforming, injection molding, or extruding the reinforced thermoplastic polyester. In one embodiment, extruding comprises additive manufacturing.
In one aspect, the invention provides an article of manufacture comprising the composite material of the above aspect and its embodiments. In one embodiment, the article is clothing, packaging, bottles, office stationary, food containers, disposable cutlery, disposable plates, toys, an article of manufacture made from plastic, injection molded articles, car parts, consumer products, building materials, products of 3D printing/additive applications, foams, automotive parts, an article that was prepared by 3D printing, biomedical articles, sutures, stents, dialysis media, and drug delivery devices.
In one aspect, a composite material is provided that is an additive-reinforced biopolyester, comprising biopolyester, and a fine particulate biobased additive that comprises thermoset biopolyester, wherein the biobased additive reinforces and nucleates the biopolyester.
In one, a biobased additive is provided for reinforcing and nucleating biopolyester, comprising a fine particulate of thermoset biopolyester, wherein the additive is suitable for reinforcing and nucleating biopolyester.
In one aspect, a method of making the composite material is provided, comprising preparing the thermoset biopolyester by heating biopolyester to a temperature sufficient to (i) melt the biopolyester, and (ii) decompose a selected free radical initiator, adding 0.5 to 2.5 wt % of the free radical initiator and 0.5 to 2.5 wt % of a crosslinking agent to the biopolyester, and mixing until thermoset biopolyester particles form, optionally forming particles by continued mixing and/or grinding the particles, and adding biopolyester to form reinforced biopolyester. In one embodiment, the adding biopolyester is performed in a melt state.
In one aspect, a method is provided of making the biobased additive of the above aspect, comprising heating biopolyester to a temperature sufficient to (i) melt the biopolyester, and (ii) decompose a selected free radical initiator, adding 0.5 to 2.5 wt % of the free radical initiator and 0.5 to 2.5 wt % of a crosslinking agent to the biopolyester, mixing until particles of thermoset biopolyester form, and optionally forming particles of smaller diameter by continued mixing and/or grinding the particles.
In one aspect, a method is provided of reinforcing and melt strengthening biopolyester, comprising adding the biobased additive to uncrosslinked biopolyester.
In one aspect, an article of manufacture is provided that comprises the composite of the above aspect. In one embodiment of all of the above aspects, the polyester is PLA.
In an embodiment of the composite material aspect, the thermoset polyester was prepared from polyester, free radical initiator, and a crosslinking agent. In one embodiment, the crosslinking agent is an allylic or acrylate crosslinking agent. In one embodiment, an amount of free radical initiator was about 0.3 to about 2.5 wt % of the thermoset polyester. In one embodiment, the free radical initiator was DCP, Luperox® L101, or Luperox® L130. In one embodiment, the crosslinking agent was TAM or TAIP. In one embodiment, the polyester is poly(lactide) (“PLA”), poly-3-(hydroxyalkanoate) (“PHA”), polycaprolactone (“PCL”), polybutylene succinate (“PBS”), poly(butylene adipate-co-terephthalate) (“PBAT”), polyethylene terephthalate (PET), or a combination thereof. In one embodiment, the amount of free radical initiator is about 1 wt % of the thermoset polyester. In one embodiment, the amount of crosslinking agent is about wt % to about 2.5 wt % of the thermoset polyester. In one embodiment, the amount of crosslinking agent is about 1 wt % of the thermoset polyester. In one embodiment, the amount of crosslinking agent is about 1 wt % and the amount of initiator is about 1 wt % of the thermoset polyester. In one embodiment, the biobased content of the composite is about 80 to about 99.9 wt %.
In one embodiment of the method aspect, adding includes dry mixing or melt compounding. In one embodiment, the method further comprises thermoforming, injection molding, or extruding the reinforced biopolyester. In one embodiment, extruding comprises additive manufacturing. In one embodiment, the biopolyester and the biopolyester of the thermoset biopolyester are the same or different. In one embodiment, the ratio of biopolyester to thermoset biopolyester is 90:10. In one embodiment, the ratio of biopolyester to thermoset biopolyester is 80:20. In one embodiment, the ratio of biopolyester to thermoset biopolyester is 85:15. In one embodiment, the ratio of biopolyester to thermoset biopolyester is 70:30.
In one embodiment the samples were conditioned isothermally at crystallization temperatures between about 80 to about 120° C.
In one embodiment of the above aspects, the biopolyester is PLA. In one embodiment, the thermoset biopolyester was prepared by mixing biopolyester, a free-radical initiator, and an allylic or acrylate crosslinking agent. In one embodiment, the biopolyester is PLA, PHA, PCL, PBS, and/or PBAT. In one embodiment, the free radical initiator is dicumyl peroxide (DCP), and the crosslinking agent is triallyl trimesate (TAM), or triallyl isocyanurate (TAIC). In one embodiment, the amount of free-radical initiator is about 0.5 wt % to about 2.5 wt %. In one embodiment, the amount of free-radical initiator is about 1 wt %. In one embodiment, the amount of crosslinking agent is about 0.5 wt % to about 2.5 wt %. In one embodiment, the amount of crosslinking agent is about 1 wt %. In one embodiment, the crosslinking agent is TAM and the free-radical initiator is DCP. In one embodiment, the amount of TAM is about 1 wt % and the amount of DCP is about 1 wt %. In one embodiment, the amount of biopolyester is about 95 to about 99 wt %.
In one embodiment of above aspects, the size of particles is a diameter or cross measurement of about 10 to about 150 μm. In one embodiment the diameter or cross measurement is less than 10 μm.
In certain embodiments, the article of manufacture is clothing, packaging, bottles, office stationary, food containers, disposable cutlery, disposable plates, toys, an article of manufacture made from plastic, injection molded articles, consumer products, building materials, products of 3D printing/additive applications, packaging, foams, automotive parts, biomedical articles, sutures, stents, dialysis media, and drug delivery devices.
In one embodiment, mixing is performed in an internal batch mixer and grinding is performed in a ball milling machine, or a wet mill microgrinder. In one embodiment of the additive aspect, the thermoset biopolyester comprises about 20% or higher of gel content.
To better understand the invention, and to show more clearly how it may be carried into effect, embodiments will be described, by way of example, with reference to the accompanying drawings, wherein:
As used herein, the term “PLA” refers to polylactide or poly(lactic acid).
As used herein, the term “PHA” refers to poly-3-(hydroxyalkanoate).
As used herein, the term “PHB” refers to polyhydroxybutyrate
As used herein, the term “PCL” refers to polycaprolactone.
As used herein, the term “PBS” refers to polybutylene succinate.
As used herein, the term “PBAT” refers to poly(butylene adipate-co-terephthalate).
As used herein, the term “PET” refers to polyethylene terephthalate.
As used herein, the term “DCP” refers to dicumyl peroxide, an example of a free radical initiator.
As used herein, the term “TAM” refers to triallyl trimesate, an example of an allylic coagent.
As used herein, the term “TAIC” refers to triallyl isocyanurate, an example of an allylic coagent.
As used herein, the term “PETA” refers to pentaerythritol triacrylate, an example of an acrylate based coagent.
As used herein, the term “TMPTMA” refers to trimethylolpropane trimethacrylate, an example of an acrylate based coagent.
As used herein, the term “BF” refers to an additive that is a nucleating and reinforcing agent that is useful for improving the thermo-mechanical properties of biopolyesters. As described herein, the BF additive is a particulate of thermoset biopolyester.
As used herein, the term “a-BF” refers to an acrylate based additive.
As used herein, the term “nucleating agent” refers to a material that induces nucleation, which refers to a first step in formation of either a new thermodynamic phase or a new structure.
As used herein, the term “BF-reinforced composite” refers to a composite material product prepared by mixing polyester and BF. In some instances, the polyester base is specified in the term, for example “BF-reinforced PLA composite”.
As used herein, the term “thermoplastic”, or “thermosoftening plastic”, is a plastic material (e.g., polymer) that becomes pliable or moldable above a specific temperature and solidifies upon cooling.
As used herein, the term “fine” in regard to particle size of BF refers to a particle size that is sufficiently small to allow the BF to reinforce and nucleate a thermoplastic polyester; for example, a particle diameter of about 10 to about 150 micrometers.
As used herein, the term “thermoset” refers to a crosslinked material that has a substantial (e.g., 20% or higher) gel content. A primary physical difference between thermoset plastics and thermoplastics is that thermoplastics can be melted and remelted back into a liquid with the application of heat, whereas thermoset plastics remain in a permanent solid state. That is, thermoset materials are non-reversibly crosslinked to an extent that they do not melt to form a liquid, thus a thermoset material would not be suitable for melt processing (e.g., not suitable to be pelletized via an extruder) when undiluted by a thermoplastic.
As used herein, the term “biobased” or “bioderived” means derived, in whole or in part, from plant, animal, marine, or forestry products.
As used herein, the term “biodegradable” means compostable or degradable under certain conditions.
As used herein, the term “biopolyester” means a polyester that is biobased, bioderived, and/or biodegradable.
As used herein, the term “conditioned” refers to a material which has been subjected to controlled crystallization conditions.
Described herein are composite materials comprising thermoplastic polyester and a particulate material that acts to reinforce the thermoplastic polyester. The particulate material comprises thermoset biopolyester. In some embodiments, the thermoplastic polyester that is reinforced is a polyester derived from non-biobased sources (e.g., petroleum based).
In one embodiment, a biobased composite material comprises a biopolyester and a bioderived additive. The presence of the bioderived additive provides improved thermo-mechanical properties to the biopolyester, without affecting its status as a fully bioderived polyester. As described in the figures and examples herein, the biobased additive is added to a biopolyester to form a composite material. The composite material, which is referred to herein as BF-reinforced biopolyester, is biobased and has improved properties, including melt strength, impact resistance, and resistance to heat distortion relative to the biopolyester in the absence of the biobased additive.
In another embodiment, a biobased additive is provided that acts as both a nucleating and a reinforcement agent when present in polyesters (e.g., biopolyesters). Other embodiments are provided such as the biobased additive.
Also described herein are methods of making the composite material and the biobased additive, and articles of manufacture prepared using the composite material.
Although the biobased additive of embodiments of the present invention can be used for any thermoplastic polyester (e.g., conventional thermoplastic polyesters such as, for example, polyethylene terephthalate (PET), polybutylene terephthalate (PBT), polycaprolactone (PCL), polyethylene succinate (PES), polybutylene succinate (PBS), and poly(butylene adipate-co-terephthalate) (PBAT) and biodegradable polyesters (e.g., PCL, PBAT, PES, PBS)), the improved properties are particularly advantageous for bioderived polyesters. Examples of thermoplastic bioderived polyesters include polylactide (PLA), poly-3-(hydroxyalkanoates) (PHAs) including polyhydroxybutyrate (PHB) and poly(3-hydroxybutyrate-co-3-hydroxyvalerate (PHBV).
Embodiments of the invention provide a biobased additive (BF) that acts as a nucleating and reinforcing agent when present in thermoplastics such as biopolyesters (e.g., biobased and/or biodegradable polyesters). BF is particularly suitable for bioplastics since a primary component of BF is biobased (e.g., PLA, PHA) or biodegradable (e.g., PCL, PBS, PBAT). Presence of BF improves thereto-mechanical properties of polyesters such as melt strength, impact resistance, and resistance to heat distortion. It also reduces or even eliminates the need for other additives such as plasticizers and traditional nucleating agents. Further, it eliminates the need for an annealing step to induce crystallization that is required for adequate processability in biopolyesters or composites thereof with traditional nucleating agents/processing additives. Advantageously, such an annealing step is not necessary for a BF-reinforced composite.
In one embodiment, a method of making BF is provided. BF has three components, its main component is a biopolyester, and there are two other components: a free-radical initiator (e.g., DCP), and a crosslinking agent (e.g., an allylic based coagent such as TAM or an acrylate based coagent such as PETA). In one embodiment, BF is prepared by mixing and heating a biopolyester. The temperature to which it should be heated should melt the biopolyester and be at or above the decomposition temperature of the initiator. Once heated, and while mixing, about 0.5 wt % to about 2.5 wt % free-radical initiator and about 0.5 wt % to about 2.5 wt % of crosslinking agent are added. Mixing continues while the crosslinking reactions occur, until a thermoset product is obtained. Although mixing, for example mechanical mixing, affects the particle size of the BF, optionally, a grinder is used to make the BF a particular particle size. Suggested BF particle size is a diameter of 10-150 micrometers. (The smaller the particle size, the more impact BF will have on reinforcing and nucleating a biopolymer.)
In one embodiment, BF is used as an additive to a biopolyester that is subsequently processed using thermoforming, injection molding, or extrusion. One example of an extrusion process is 3D printing. In one embodiment, BF is prepared from dried PLA that has been compounded (i.e., melt mixed) with DCP and TAM. Results provided herein show that the presence of 10 wt % BF in a biopolyester composite decreased the crystallization half-time of the biopolyester composite by ten-fold. A suggested range of the amount of BF in the biopolyester composite is from about 1 wt % to about 50 wt %.
In one embodiment, a BF-reinforced composite is provided that is prepared from a biopolyester and a thermoset additive prepared from: a biopolyester; a crosslinking initiator; and an allylic based coagent. In one embodiment, a BF-reinforced composite is provided that is prepared from a polyester, a crosslinking initiator and an acrylate based coagent. Examples of allylic based coagents include TAM, or TAIC, An example of an acrylate based coagent is PETA.
An example of a crosslinking initiator is DCP. Other examples include Luperox® L101, Luperox® L130.
PLA can be processed using conventional thermoplastics processing equipment including injection molding, blow molding, film casting, etc. However, PLA has a narrow processing window because of its sensitivity to processing temperatures that are too high above its melting point. Additionally, PLA has a lack of melt strength, a slow crystallization rate, and is considered to have poor engineering properties such as impact strength and heat distortion resistance. Such drawbacks have limited the applicability of PLA to low-cost commodity applications (e.g., food packaging) and biomedical applications (e.g., drug delivery) where biocompatibility and biodegradability are desired.
Properties of PLA depend significantly on its molecular weight and the stereochemical makeup of its polymer backbone which is controlled by polymerization with D-lactide, L-lactide, or D,L-lactide, to form random or block stereocopolymers. The rheological properties of PLA depend on the molecular weight and molecular weight distributions (MWD), presence of branching, and the stereochemical makeup. Commercially available linear PLA is reported to lack the level of strain hardening, and therefore melt strength, needed for normal processing operations, limiting the success of PLA in operations involving high stretch rates such as film blowing, thermoforming, and foaming.
Nucleating agents are commonly added to impart crystallinity, or to enhance crystallization kinetics (Li, H., et al., Polymer, 48(23), 6855-6866 (2007), Withey R. E., et al., Polymer, 40(18), 5147-5152 (1999).). Nucleating agents work by providing sites around which polymer chains can crystallize. They can alter the crystallization temperature and thus the rate of crystallization. For neat PLA, even with the addition of nucleating agents, an annealing step is still required to induce crystallization, and to obtain satisfactory heat distortion resistance. Generally in PLA the maximum achievable crystallinity is dictated by the amount of D-lactide. Mixtures of D-lactide and L-lactide based PLA can crystallize in the form of a stereocomplex, which improves the temperature resistance of the material, while also acting as a nucleating agent for the crystallization of PLA.
Various nucleating agents have been tested in PLA and PHB formulations to promote crystallization including talc, sodium stearate, calcium lactate etc., often together with a plasticizer. Various nanofillers have also been tested in PLA, and PHAs. More recently, biobased cellulosic additives, such as cellulose nanowhiskers, nanofibers, and nanocrystals have been used to achieve reinforcement and to increase the crystallization rate of biopolymers, while maintaining the completely biobased nature of the formulations. This approach comes with many challenges, given the incompatibility with polymer matrices, which necessitates the use of various functionalization methods, such as silylation of the cellulose nanocrystals.
Advantageously, the reinforced biopolyester is substantially all biobased. Assuming 10% for an amount of reinforcing additive and 90% as the amount of matrix biopolymer, with the additive being 2% DCP and TAM, the resulting amount is 0.2% non-biobased material and 99.8% biobased material. Assuming 2% for an amount of reinforcing additive results in an even higher amount of biobased material.
In one embodiment, an article of manufacture is provided that is made from BF-reinforced composite materials, prepared from mixing BF and polyesters (e.g., PLA, PHA and/or PCL). Such articles include a wide range of articles from clothing, packaging (e.g., clam shell type food packaging), bottles, office stationary, food containers, disposable cutlery, disposable cups, disposable plates, toys, an article of manufacture made from plastic, injection molded articles, consumer products, building materials, products of 3D printing/additive manufacturing, packaging, foams, and automotive applications. PLA, as well as PHAs and PCL are used in biomedical applications. Accordingly, BF-reinforced PLA, BF-reinforced PHA, and BF-reinforced PCL offer improved properties and are also suitable for use to prepare biomedical articles, such as sutures, stents, dialysis media, and drug delivery devices.
As described in the Working Examples and shown in the figures, tests were conducted to quantify the effect of the presence of various amounts of BF and a-BF in BF-reinforced PLA composite material samples versus neat PLA.
Referring to
Referring to
Referring to
Referring to
where ΔHc, ΔHcc and ΔHom are the enthalpy of fusion, and enthalpy of cold crystallization of the component and the melting enthalpy of perfectly crystalline PLA (93.6 J/g), respectively, and ϕPLA is the matrix weight percent in the samples.
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Notably, the composite materials described herein have been shown to possess improved impact properties. As described in the Working Examples and shown in the figures, a variety of improved properties of BF-reinforced biopolyester relative to neat biopolyester have been observed and quantified. Samples of BF were tested for gel content as described in Example 9. A gel content of about 90% or higher was determined for a representative example of BF. Gel content of about 20% or higher is expected to have the reinforcing and nucleating effect on biopolyester that was shown herein. A gel content of about 20% of higher is not significantly deformed in the presence of heat and remains solid (i.e, does not melt) in the presence of heat and therefore is not suitable for melt processing.
The following working examples further illustrate embodiments of the invention and are not intended to be limiting in any respect.
Polylactide or PLA used in experiments described herein was PLA 3251D and was purchased from NatureWorks LLC Co. (USA). The selected grade is a semi-crystalline linear polymer with melt flow rate (MFR) of 35 g/10 min under a load of 2.16 kg at 190° C., and 80 g/10 min at 210° C. (ASTM D1238), as reported by the manufacturer. Dicumyl peroxide (DCP) and triallyl-trimesate (TAM), supplied by Sigma Aldrich and Monomer Polymer & Dajac Labs, respectively, were used as initiator and crosslinking agent in this work, respectively.
Melt compounding of PLA with initiator and crosslinking agent was performed using a Haake Polylab R600 internal batch mixer. Before compounding, the PLA was dried at 60° C. in a vacuum oven for 24 h. The dried PLA was then directly mixed in the molten state with 1 wt % of dicumyl peroxide (DCP) and 1 wt % of triallyl trimesate (TAM), trimethylolpropane trimethacrylate (TMPTMA) at a set temperature of 185° C. The mixing was conducted at a rotation speed of 120 rpm for 10 min. The PLA was chemically reacted with the cross-linking agents during the melt compounding leading to the production of an agglomeration of thermoset (i.e., cross-linked) polymer. The thermoset polymer was then ground using a grinder to smaller size detached particles. A particulate of thermoset PLA that has a particulate diameter of about 10 to about 150 micrometers is referred to herein as BF.
The melt mixing of PLA with various quantities of BF (1, 5, 7, 10, 20 and 50 wt %) and a-BF (5 wt %) was carried out using the laboratory internal mixer (Haake) for 5 min under the aforementioned conditions.
The melt mixing of PHB with 5 wt % of BF was carried out using the Haake mixer under the aforementioned conditions. Based on preliminary results, the use of PHB does not offer any improvements compared with the PLA based materials.
To further investigate the effects of scale-up on the properties of the BF samples, melt mixing of PLA with 5 wt % BF was performed using a twin screw corotating extruder (Coperion ZSK 18 ML). The temperature profile was 170/190/190/190/190/190/190° C. (hopper to die). The extrusion was performed at a feeder speed of 30 min−1 with a screw speed of 120 min−1 and an average residence time of 2.5 min. No significant differences in thermal properties were detected between the Haake and Coperion processed samples.
Samples were subjected to controlled crystallization conditions using a Carver Hydraulic Press. The conditioned samples were molded at 190° C. for 5 minutes and were transferred to a compression molding machine at 100° C. After 5 minutes the mold was removed and the samples were extracted.
The prepared disk-shaped samples were used to measure dynamic rheological properties. Small amplitude oscillatory shear (SAGS) experiments were conducted using a rotational rheometer with parallel plate flow geometry of 25 mm diameter and 1.0 mm gap size.
The non-isothermal and isothermal melt-crystallization behavior of the samples were investigated using a differential scanning calorimeter, DSC-Q 1000 (TA Instruments, USA) under a N2 atmosphere. In initial tests, samples (˜10 mg) encapsulated in aluminum standard pans, heated at a scanning rate of 10° C./min from 30 to 190° C. and held for 5 min at this temperature. Samples were then cooled down to 30° C. at a rate of 5° C./min to determine the crystallization enthalpy (ΔHc) and degree of crystallinity (Xc).
In subsequent tests, samples were heated from 30 to 210° C. at a rate of 5° C./min and held for 5 min at this temperature. Samples were cooled down to −30° C. at a rate of 5° C./min.
The isothermal melt-crystallization behavior was studied at 90 to 130° C. All the specimens were first heated at 60° C./min to 200° C. and held there for 5 min. The molten samples were then cooled down to crystallization temperature (Tc) at 50° C./min. The samples were kept at Tc until the crystallization was complete.
Tensile and flexural properties were determined from the compression molded dog-bone and rectangular specimens, respectively. The samples were molded at 190° C. and were subsequently conditioned at 100° C. in temperature controlled compression molding platens. Tensile testing was performed according to ASTM D 638 on an Instron tensile machine equipped with a 5 kN load cell and a cross head speed of 5 mm min−1. Flexural tests were performed according to ISO 178 with a cross head speed of 2 mm min−1. All the mechanical tests were performed 48 h after molding and the reported values were obtained by averaging over eight specimens for each composition.
The rectangular compression molded bars that were conditioned at 100° C. were used to obtain the impact strength of composites of PLA and various amounts of BF particles. The Izod impact test was performed on notched samples using a pendulum impact tester (available from Satec System Inc.), according to ASTM D256. The values reported here are the averages of five specimens for each composition.
Specimens (127 mm×13 mm×3 mm) were prepared by compression molding using a Carver Hydraulic Press at 190° C. with a residence time of 5 minutes. The mold was removed and cooled at 100° C. for 5 minutes. Specimens were lowered in a silicon oil bath, and the temperature was increased from 23° C. at a heating rate of 120° C./h until 0.25 mm deflection occurred under a load of 1.82 MPa, in accordance with ASTM D648. At least three specimens were tested, and the average value was reported.
The complex viscosity (η*) and elastic modulus (G′) of the processed PLA (PPLA) and BF-reinforced PLA with specified BF amounts were plotted as functions of frequency (w) at 190° C. in
The isothermal crystallization behaviors of PLA and BF-reinforced PLA composites was investigated by DSC. Results in the form of thermograms for all systems at Tc of 130° C. are presented in
To further analyze the effect of BF on the crystallization behavior of PLA, the isothermal crystallization behavior of BF-reinforced PLA with 10 wt % BF was investigated in a temperature ranging from 90 to 130° C. The crystallization half times (t1/2) were calculated and plotted in
An optical microscope (Olympus BX51, Toronto, Canada) was used to observe compression molded specimens, BF was found to be evenly dispersed in one of the embodiments (10 wt %). Particle size ranged from 20 μm to 100 μm.
Gel content analysis of BF was conducted by extraction into boiling chloroform from a 120 mesh stainless steel sieve for 6 hours, according to ASTM D 2765 (Takamura, M., et al., Polym. Degrad. Stabil., 93 (2008) 1909-1916, and Sen-lin Yang, et al., Polymer Testing 27 (2008) 957-963).
Residual polymer was dried to constant weight, with gel content reported as a weight percentage of unextracted material. Gel contents of PLA samples have been quantified as low as 3 wt %, which is considered the detection limit, and as high as fully crosslinked. Gel content amounts between these low and high amounts are possible depending on the amounts of crosslinking agent(s).
Samples of BF were tested and found to be insoluble in chloroform. This result was interpreted as indicative of a gel content of about 90% or higher.
Hydrolytic degradation tests were conducted at 60° C. in a Thermo Scientific Forma 3911 environmental chamber. Individual films with 1×3 cm2 dimensions and a thickness of 200 μm were placed in tared scintillation vials containing 20 ml of phosphate buffer solution. On a weekly basis, two samples per formulation were extracted for further characterization and the PBS was replaced for all remaining vials.
Gel permeation chromatography (GPC) was performed using a Viscotek 270 max separation module equipped with triple detectors: differential refractive index (DRI), viscosity (IV), and light scattering (low angle, LALS and right angle, RALS). The separation module was maintained at 40° C. and contained two porous PolyAnalytik columns in series with an exclusion molecular weight limit of 20×106 g·mol-1. HPLC grade THF was used as the eluent at a flow rate of 1 mL·min−1. Samples were prepared for GPC analysis by dissolving film cross-sections in THF to achieve solutions with concentrations of 2.5 mg ml−1.
In preliminary tests, BF did not significantly impact the degradation of PLA. After 5 weeks of hydrolytic exposure, both non-BF reinforced PLA and PLA with 1 wt % BF were observed to undergo 94% loss in molar mass and 17% loss in mass. Also shown in
All publications listed and cited herein are incorporated herein by reference in their entirety. It will be understood by those skilled in the art that this description is made with reference to certain preferred embodiments and that it is possible to make other embodiments employing the principles which fall within its spirit and scope as defined by the claims.
| Number | Name | Date | Kind |
|---|---|---|---|
| 4626570 | Gardner | Dec 1986 | A |
| 6110983 | Tokoro et al. | Aug 2000 | A |
| 20080182924 | Morimoto | Jul 2008 | A1 |
| 20100292381 | Kamikawa | Nov 2010 | A1 |
| 20150051320 | Huang et al. | Feb 2015 | A1 |
| Number | Date | Country |
|---|---|---|
| 2617032 | Jul 2008 | CA |
| 2775181 | May 2011 | CA |
| 1813648 | Aug 2007 | EP |
| 3159127 | Apr 2017 | EP |
| WO199509202 | Apr 1995 | WO |
| Entry |
|---|
| U.S. Appl. No. 16/629,335, filed Jan. 8, 2020, Chaloupli, N. et al. |
| International Search Report and Written Opinion for corresponding International Patent Application No. PCT/CA2018/050844. |
| European Examination Report dated Oct. 4, 2022 for corresponding European Application No. 18832889.2. |
| Number | Date | Country | |
|---|---|---|---|
| 20230193022 A1 | Jun 2023 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62531107 | Jul 2017 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16629335 | US | |
| Child | 18083106 | US |
